IN8bio Inc (NASDAQ:INAB) concluded the trading at $0.12 on Wednesday, June 04 with a fall of -0.97% from its closing price on previous day.
Considering stock’s 52-week price range provides that INAB hit a high price of $1.74 and saw its price falling to a low level of $0.11 during that period. Over a period of past 1-month, stock came subtracting -26.56% in its value.
According to ratings assigned by 2 analysts at the scale of 1 to 5 with 1.00 representing a strong buy and 5.00 suggesting a strong sell; 0 of them are recommending IN8bio Inc (INAB) as a Hold, while 2 are in view that stock is a Buy. Recommendation by 0 analysts for the stock is an Underweight while number of those analysts who rated the stock as an Overweight is 0, whereas 0 of them are considering the stock as a Sell. When taken as whole, stock gets a rating of Overweight and that encourages the investors to exploit the opportunity and build their stake up in the company.
Digging deeper we become aware of the PEG ratio of the INAB stock which is currently positioned at 0. It further provides that stock’s current price level is -13.94% away from its 20-day simple moving average and is -23.21% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 34.75 while volatility remained at 4.20% over the past week which changes to 5.55% when measuring it over the past month. Beta is valued at 0.18, while measure of average true range or ATR is currently at 0.02.
The percentage of outstanding shares held by the insiders is 21.49% while it is 17.96% for the institutional holders. Subtraction of -52.37% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
